Endocannabinoid Receptor Antagonists: Potential for Obesity Treatment

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.3, Iss.6, 2004-01, pp. : 345-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxyntomodulin: A Novel Potential Treatment for Obesity

By Druce Maralyn R. Bloom Stephen R.

Treatments in Endocrinology, Vol. 5, Iss. 5, 2006-01 ,pp. : 265-272

Adis International

Access to resources Recommend Favorite

Treatment Persistence with Leukotriene Receptor Antagonists and Inhaled Corticosteroids

By Dorais Marc Blais Lucie Chabot Isabelle LeLorier Jacques

Journal of Asthma, Vol. 42, Iss. 5, 2005-06 ,pp. : 385-393

Informa Healthcare

Access to resources Recommend Favorite

Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists

By Iyengar Srinivas Rabbani LeRoy

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 300-306

Springer Publishing Company

Access to resources Recommend Favorite

Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists

By Grammatopoulos D.K. Chrousos G.P.

Trends in Endocrinology and Metabolism, Vol. 13, Iss. 10, 2002-12 ,pp. : 436-444

Elsevier

Access to resources Recommend Favorite

Hypothalamic regulatory pathways and potential obesity treatment targets

By Jobst Erin Enrioi Pablo Sinnayah Puspha Cowley Michael

Endocrine Journal, Vol. 29, Iss. 1, 2006-02 ,pp. : 33-48

Humana Press, Inc

Access to resources Recommend Favorite